# SynapDx Autism Gene Expression Analysis Study

> **NCT01716845** · — · COMPLETED · sponsor: **SynapDx** · enrollment: 660 (estimated)

## Conditions studied

- Autism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01716845
- **Lead sponsor:** SynapDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 660 (ESTIMATED)
- **Last updated:** 2014-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716845, "SynapDx Autism Gene Expression Analysis Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01716845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*